These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9308909)

  • 1. A general strategy for the expression of recombinant human cytochrome P450s in Escherichia coli using bacterial signal peptides: expression of CYP3A4, CYP2A6, and CYP2E1.
    Pritchard MP; Ossetian R; Li DN; Henderson CJ; Burchell B; Wolf CR; Friedberg T
    Arch Biochem Biophys; 1997 Sep; 345(2):342-54. PubMed ID: 9308909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5' modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase.
    Gillam EM; Wunsch RM; Ueng YF; Shimada T; Reilly PE; Kamataki T; Guengerich FP
    Arch Biochem Biophys; 1997 Oct; 346(1):81-90. PubMed ID: 9328287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cytochrome P450 2A6 in Escherichia coli: purification, spectral and catalytic characterization, and preparation of polyclonal antibodies.
    Soucek P
    Arch Biochem Biophys; 1999 Oct; 370(2):190-200. PubMed ID: 10510277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of recombinant CYP3A4 expression in Chinese hamster ovary cells are modulated by coexpressed human P450 reductase and hemin supplementation.
    Ding S; Yao D; Burchell B; Wolf CR; Friedberg T
    Arch Biochem Biophys; 1997 Dec; 348(2):403-10. PubMed ID: 9434754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: regional and inter-individual variation in expression and relevance to nitrosamine metabolism.
    Godoy W; Albano RM; Moraes EG; Pinho PR; Nunes RA; Saito EH; Higa C; Filho IM; Kruel CD; Schirmer CC; Gurski R; Lang MA; Pinto LF
    Carcinogenesis; 2002 Apr; 23(4):611-6. PubMed ID: 11960914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering human cytochrome P450 enzymes into catalytically self-sufficient chimeras using molecular Lego.
    Dodhia VR; Fantuzzi A; Gilardi G
    J Biol Inorg Chem; 2006 Oct; 11(7):903-16. PubMed ID: 16862439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme.
    Gillam EM; Baba T; Kim BR; Ohmori S; Guengerich FP
    Arch Biochem Biophys; 1993 Aug; 305(1):123-31. PubMed ID: 8342945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competition between cytochrome P-450 isozymes for NADPH-cytochrome P-450 oxidoreductase affects drug metabolism.
    Li DN; Pritchard MP; Hanlon SP; Burchell B; Wolf CR; Friedberg T
    J Pharmacol Exp Ther; 1999 May; 289(2):661-7. PubMed ID: 10215637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A universal approach to the expression of human and rabbit cytochrome P450s of the 2C subfamily in Escherichia coli.
    Richardson TH; Jung F; Griffin KJ; Wester M; Raucy JL; Kemper B; Bornheim LM; Hassett C; Omiecinski CJ; Johnson EF
    Arch Biochem Biophys; 1995 Oct; 323(1):87-96. PubMed ID: 7487078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human cytochrome P450 enzymes by the natural hepatotoxin safrole.
    Ueng YF; Hsieh CH; Don MJ
    Food Chem Toxicol; 2005 May; 43(5):707-12. PubMed ID: 15778010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcellular localization, aggregation state, and catalytic activity of microsomal P450 cytochromes modified in the NH2-terminal region and expressed in Escherichia coli.
    Pernecky SJ; Olken NM; Bestervelt LL; Coon MJ
    Arch Biochem Biophys; 1995 Apr; 318(2):446-56. PubMed ID: 7733676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of cytochrome P450 2A6 and 2E1 gene expression in primary human bronchial epithelial cells.
    Crawford EL; Weaver DA; DeMuth JP; Jackson CM; Khuder SA; Frampton MW; Utell MJ; Thilly WG; Willey JC
    Carcinogenesis; 1998 Oct; 19(10):1867-71. PubMed ID: 9806171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase.
    Kushida H; Fujita K; Suzuki A; Yamada M; Endo T; Nohmi T; Kamataki T
    Carcinogenesis; 2000 Jun; 21(6):1227-32. PubMed ID: 10837014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temperature effect on the functional expression of human cytochromes P450 2A6 and 2E1 in Escherichia coli.
    Yim SK; Ahn T; Jung HC; Pan JG; Yun CH
    Arch Pharm Res; 2005 Apr; 28(4):433-7. PubMed ID: 15918516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies against cytochromes P-4502E1 and P-4503A in alcoholics.
    Lytton SD; Helander A; Zhang-Gouillon ZQ; Stokkeland K; Bordone R; Aricò S; Albano E; French SW; Ingelman-Sundberg M
    Mol Pharmacol; 1999 Feb; 55(2):223-33. PubMed ID: 9927612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: effects of cytochrome P450-P450 and cytochrome P450-b5 interactions.
    Yamazaki H; Gillam EM; Dong MS; Johnson WW; Guengerich FP; Shimada T
    Arch Biochem Biophys; 1997 Jun; 342(2):329-37. PubMed ID: 9186495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparative synthesis of drug metabolites using human cytochrome P450s 3A4, 2C9 and 1A2 with NADPH-P450 reductase expressed in Escherichia coli.
    Vail RB; Homann MJ; Hanna I; Zaks A
    J Ind Microbiol Biotechnol; 2005 Feb; 32(2):67-74. PubMed ID: 15739102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dehydrogenation of indoline by cytochrome P450 enzymes: a novel "aromatase" process.
    Sun H; Ehlhardt WJ; Kulanthaivel P; Lanza DL; Reilly CA; Yost GS
    J Pharmacol Exp Ther; 2007 Aug; 322(2):843-51. PubMed ID: 17502430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Caco-2 cells expressing high levels of cDNA-derived cytochrome P4503A4.
    Crespi CL; Penman BW; Hu M
    Pharm Res; 1996 Nov; 13(11):1635-41. PubMed ID: 8956327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphism of CYP2A6 in relation to cancer.
    Kamataki T; Nunoya K; Sakai Y; Kushida H; Fujita K
    Mutat Res; 1999 Jul; 428(1-2):125-30. PubMed ID: 10517986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.